We are international
Donate
publications TEXT SIZE   
meeting highlights    back

Amplification of 1q21 Is Associated with Poor Outcome after Treatment with Bortezomib in Relapsed/Refractory Multiple Myeloma
By Heinz Ludwig, MD
12.17.06

Be the first to comment

 related articles